Print Page
Our Experts

Our scientists, policy experts, researchers and analysts integrate an understanding of the scientific and policy environments, scientific literature and research, data analysis to meet each individual client's needs.

Where We Will Be

You can meet PinneyAssociates at scientific meetings throughout the year.

Our Experts

We are a multidisciplinary group of experienced scientists, policy experts, analysts, research assistants, and support staff.  In addition to our core staff, we collaborate with a select pool of scientific, technical and medical consultants from leading institutions.
  • Sidney H. Schnoll, MD, PhD, Vice President, Pharmaceutical Risk Management Services
    Sidney H. Schnoll, MD, PhD's photo

    Sidney H. Schnoll, MD, PhD is an internationally recognized expert in addiction and pain management who applies his experience of over 30 years in academic medicine to the issues of risk management. Dr. Schnoll counsels clients on regulatory and scientific strategy, and development, implementation and assessment of risk management activities. Dr. Schnoll leads efforts to conduct risk assessment during early product development, develop Risk Evaluation and Mitigation Strategies (REMS), and develops post-marketing surveillance reports for submission to FDA.

    Dr. Schnoll has served on numerous committees and boards including the FDA's Drug Abuse Advisory Committee (DAAC), NIH study sections, National Board of Medical Examiners test development committees, and the board of the College on Problems of Drug Dependence (CPDD).

    Dr. Schnoll was a member of the team that developed the Tramadol Independent Steering Committee (ISC), which resulted in Ultram being launched as an unscheduled analgesic and monitored for abuse and diversion of tramadol.  As part of the ISC, he was the principal investigator on the health care professional surveillance project.  In 2001, Dr. Schnoll joined Purdue Pharma L.P. where he developed the RADARS® System to study the abuse and diversion of prescription opioids.

    Dr. Schnoll attended Union College, and the New Jersey College of Medicine and Dentistry where he received his M.D. degree.  He did his internship, residency in Neurology and Ph.D. in Pharmacology at Jefferson Medical College.  He was the Career Teacher in Addictions at the University of Pennsylvania, following which he was Medical Director at the Eagleville Hospital and Rehabilitation Center, which is noted for many innovations in the treatment of addictive diseases.  In 1980, he became Associate Professor of Psychiatry and Pharmacology and Director of Chemical Dependence programs at Northwestern University Medical School.  In 1986, he became Professor of Internal Medicine and Psychiatry at the Medical College of Virginia, Virginia Commonwealth University and Chairman of the Division of Substance Abuse Medicine.  He currently is a Voluntary Professor of Behavioral Science at the University of Kentucky.

    Dr. Schnoll has received numerous awards including listings in The Best Doctors in America and is a Fellow of CPDD and the American Society of Addiction Medicine.

    Dr. Schnoll has published over 150 research papers, book chapters and educational materials.  His areas of research include both addiction and pain management with special emphasis on prescription drug abuse  and perinatal addiction.